[Zrytec drops in the treatment of allergy rhinitis in children].
To assess the efficacy and safety of Zyrtec drops which is a patent product of UCB pharma in treatment of allergy rhinitis in children. A total of 47 children of both sexes aged between 2 to 6 years with allergy rhinitis (AR) were included in this study, who were randomly selected to be treated with Zyrtec (Cetirizine 2 HCL) drops 5 mg daily for 3 weeks. Investigators made a global evaluation with symptom scores before treatment and once a week for 3 weeks after treatment. An improvement was shown in each week after treatment with statistical significance (P < 0.01). Zyrtec drops provided an excellent improvement at the end of the study. Tolerance was good. For acting fast, potent, good tolerance and convenience in use, Zyrtec drops is a better treatment in AR in kids.